The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round ...

In late 2024, the Centers for Medicare and Medicaid Services previewed a significant revision to the risk-adjustment model ...

How a coordinated care team and other support can help you manage chronic conditions like diabetes and heart disease.

As the home health industry still awaits the final Medicare home health payment rule, the National Alliance for Care at Home ...

There’s a wide range of Medicare health insurance plans available to adults age 65 and older (and some younger individuals with qualifying disabilities), and it can be confusing trying to decide which ...

Orforglipron is Lilly’s oral GLP-1 in phase 3 development as a treatment for diabetes and obesity. The FDA is expected to approve the drug in March 2026. Lilly’s November news release states that the ...

In the same way imaging and biomarker analytics revolutionized cancer and cardiology, AI-driven cognitive analytics will redefine brain health, says one CEO. Next year may be when private insurers ...

Our analysis shows that the introduction of a POH could negatively impact the financial health of existing SCHs by siphoning profitable service types and reducing their proportion of healthier, ...

Arkansas is no longer anticipating its proposed "Pathway to Prosperity" initiative to be launched on Jan. 1, instead seeking ...

Seen Health today announced strong early results from its culturally-focused Program of All‑Inclusive Care for the Elderly (PACE), demonstrating that an AI‑native operating model can deliver faster ...

Centers for Medicare & Medicaid Services (CMS) Administrator Mehmet Oz, M.D., sought to make inroads with the bristling ...

Senate Democrats are demanding that President Trump release the list of the most recent Medicare-negotiated drug prices.